| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
| | IP | CI | | Fosamax 70 mg - T | 4 Tablet(s) | 17.76 | 35.65 | 10 % | | Tablets: Acidum Alendronicum 70 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | IP | CI | | Fosamax 70 mg - T | 12 Tablet(s) | 51.11 | 71.80 | 10 % | | Tablets: Acidum Alendronicum 70 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | IP | CI | | Alendronat Sandoz 70 | 4 | 16.19 | 34.05 | 10 % | | Coated tablets: Acidum Alendronicum 70 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Alendronat Sandoz 70 | 12 | 46.60 | 67.20 | 10 % | | Coated tablets: Acidum Alendronicum 70 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Alendronat Spirig HC 70 mg | 4 Tablet(s) | 16.19 | 34.05 | 10 % | | Tablets: Acidum Alendronicum 70 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Alendronat Spirig HC 70 mg | 12 Tablet(s) | 46.60 | 67.20 | 10 % | | Tablets: Acidum Alendronicum 70 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Alendronat Zentiva | 4 | 15.00 | 32.85 | 10 % | | Weekly tablets: Acidum Alendronicum 70 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Alendronat Zentiva | 12 | 43.39 | 63.90 | 10 % | | Weekly tablets: Acidum Alendronicum 70 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Alendron-Mepha 70 mg | 4 Tablet(s) | 16.17 | 34.05 | 10 % | | Filmtablette: Acidum Alendronicum 70 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Alendron-Mepha 70 mg | 12 Tablet(s) | 46.60 | 67.20 | 10 % | | Filmtablette: Acidum Alendronicum 70 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Binosto 70 mg | 4 Tablet(s) | 17.42 | 35.30 | 10 % | | Comprimés effervescents: Acidum Alendronicum 70 mg | Labatec Pharma SA | B / SL | FB | | G |  |
| | IP | CI | | Binosto 70 mg | 12 | 44.43 | 64.95 | 10 % | | Comprimés effervescents: Acidum Alendronicum 70 mg | Labatec Pharma SA | B / SL | FB | | G |  |
|
L | | IP | CI | | Bonviva i.v. | syringe(s) | 49.01 | 69.40 | 20 % | | Injection solution: Acidum Ibandronicum 3mg / 3ml | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Bonviva 150 mg ‐ I | Tablet(s) | 17.06 | 35.00 | 10 % | | Coated tablets: Acidum Ibandronicum 150 mg | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Bonviva 150 mg ‐ I | 3 Tablet(s) | 46.57 | 67.25 | 10 % | | Coated tablets: Acidum Ibandronicum 150 mg | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
L | | IP | | | Ibandronat Sandoz i.v. | syringe(s) | 44.11 | 64.35 | 10 % | | Injection solution: Acidum Ibandronicum 3mg / 3ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | | | Ibandronat Spirig HC i.v. 3 mg/3 ml | Fertigspritze(n) | 44.11 | 64.35 | 10 % | | Injection solution: Acidum Ibandronicum 3mg / 3ml | Spirig HealthCare AG | ● B / SL / SG | FB | | G |  |
L | | IP | | | Ibandronat Zentiva Osteo | | 44.11 | 64.35 | 10 % | | Injection solution: Acidum Ibandronicum 3mg / 3ml | Helvepharm AG | B / SL / SG | FB | | G |  |
L | | IP | | | Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml | Fertigspritze(n) | 42.35 | 62.55 | 10 % | | Injection solution in prefilled syringe: Acidum Ibandronicum 3mg / 3ml | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Ibandronat Sandoz 150 | Tablet(s) | 14.43 | 32.30 | 10 % | | Coated tablets: Acidum Ibandronicum 150 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Ibandronat Sandoz 150 | 3 Tablet(s) | 41.91 | 62.50 | 10 % | | Coated tablets: Acidum Ibandronicum 150 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | CI | CM | Ibandronat Spirig HC 150 mg Monatstabletten | | 14.43 | 32.30 | 10 % | | Coated tablets: Acidum Ibandronicum 150 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | CI | CM | Ibandronat Spirig HC 150 mg Monatstabletten | 3 | 41.91 | 62.50 | 10 % | | Coated tablets: Acidum Ibandronicum 150 mg | Spirig HealthCare AG | ● B / SL / SG | FB | | G |  |
L | | IP | CI | | Ibandronat-Mepha 150 mg Monatstabletten | | 14.43 | 32.30 | 10 % | | Coated tablets: Acidum Ibandronicum 150 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | IP | CI | | Ibandronat-Mepha 150 mg Monatstabletten | 3 | 41.91 | 62.50 | 10 % | | Coated tablets: Acidum Ibandronicum 150 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | IP | CI | | Bondronat 6 mg/6 ml | Durchstechflasche(n) | 178.71 | 210.75 | 10 % | | Concentrate for infusion: Acidum Ibandronicum 6mg / 6ml | Atnahs Pharma Switzerland AG | B / SL | FB | | G |  |
| | | | | Bonames Filmtabletten | Tablet(s) | PR | PR | k.A. | | | Recordati AG | B | FB | | G |  |
| | | | | Bonames Filmtabletten | 3 Tablet(s) | PR | PR | k.A. | | | Recordati AG | B | FB | | G |  |
|
| | IP | CI | | Actonel 35 mg | 4 | 15.44 | 33.20 | 10 % | | Gastric juice resistant tablets: Natrii Risedronas 35 mg | Future Health Pharma GmbH | B / SL | FB | | G |  |
| | IP | CI | | Actonel 35 mg | 12 | 43.53 | 63.75 | 10 % | | Gastric juice resistant tablets: Natrii Risedronas 35 mg | Future Health Pharma GmbH | B / SL | FB | | G |  |
L | | IP | CI | | Actonel 35 mg Wochentabletten | 4 Tablet(s) | 15.44 | 33.20 | 10 % | | Coated tablets: Natrii Risedronas 35 mg | Future Health Pharma GmbH | B / SL | FB | | G |  |
L | | IP | CI | | Actonel 35 mg Wochentabletten | 12 Tablet(s) | 43.53 | 63.75 | 10 % | | Coated tablets: Natrii Risedronas 35 mg | Future Health Pharma GmbH | B / SL | FB | | G |  |
| | IP | CI | | Actonel 30 mg | 28 Tablet(s) | 241.96 | 294.15 | k.A. | | Coated tablets: Natrii Risedronas 30 mg | Future Health Pharma GmbH | B | FB | | G |  |
|
| | | | | Zoledronat Onco Labatec, 4 mg/100 ml | 100 ml | PR | PR | k.A. | | Infusion solution: Acidum Zoledronicum 4mg / 100ml | Labatec Pharma SA | B | FB | | G |  |
L | | IP | | | Aclasta | Durchstechflasche(n) à 100 ml | 219.40 | 254.45 | 10 % | | Infusion solution: Acidum Zoledronicum 5mg / 100ml | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Zometa 4 mg/5 ml | Durchstechflasche(n) | 165.83 | 193.10 | 20 % | | Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
L | | IP | | | Zoledronat OSTEO Labatec | | 186.49 | 220.65 | 10 % | | Infusion solution: Acidum Zoledronicum 5mg / 100ml | Labatec Pharma SA | B / SL / SG | FB | | G |  |
L | | IP | | CM | Zoledronat Osteo Sandoz 5 mg/100 ml | Durchstechflasche(n) | 186.49 | 220.65 | 10 % | | Infusion solution: Acidum Zoledronicum 5mg / 100ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | | | Zoledronat Osteo Spirig HC 5 mg/100 ml | | 186.49 | 220.65 | 10 % | | Infusion solution: Acidum Zoledronicum 5mg / 100ml | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | | | Zoledronsäure Onco Sandoz 4 mg / 100 ml | 100 ml | 108.31 | 134.10 | 10 % | | Infusion solution: Acidum Zoledronicum 4mg / 100ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | IP | | | Zoledronat Accord onco 4 mg/5 ml | | 105.85 | 131.55 | 10 % | | Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml | Accord Healthcare AG | B / SL / SG | FB | | G |  |
| | IP | | | Zoledronat Fresenius Onco 4 mg/5 ml | Durchstechflasche(n) | 98.47 | 124.00 | 10 % | | Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml | Fresenius Kabi (Schweiz) AG | B / SL / SG | FB | | G |  |
| | IP | | | Zoledronat Onco Labatec 4 mg/5 ml | Durchstechflasche(n) | 108.31 | 134.10 | 10 % | | Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml | Labatec Pharma SA | B / SL / SG | FB | | G |  |
| | IP | | | Zoledronat-Teva onco 4 mg/ 5 ml | | 108.31 | 134.10 | 10 % | | Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml | Teva Pharma AG | B / SL / SG | FB | | G |  |
| | IP | | CM | Zoledronsäure Onco Sandoz 4 mg/5 ml | Durchstechflasche(n) | 108.31 | 134.10 | 10 % | | Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | IP | | | Eotriz 4 mg/5 ml | | PR | PR | k.A. | | Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml | SciClone Pharmaceuticals Switzerland GmbH | B | FB | | G |  |
| | IP | | | Zoledronat-Acino Osteo 5mg | Durchstechflasche(n) | PR | PR | k.A. | | Infusion solution: Acidum Zoledronicum 5mg / 100ml | Acino Pharma AG | B | FB | | G |  |